SCHEMBL32688430

SCHEMBL32688430

N#Cc1c(S)[nH]c(=O)c(C#N)c1-c1cccc(-c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE9A O76083 2/20 0.50
▸ ATM Q13315 1/20 0.48
▸ IDO1 P14902 3/20 0.47
▸ KDM4E B2RXH2 5/20 0.47
▸ GAA P10253 2/20 0.47
▸ TDO2 P48775 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ HPGD P15428 3/20 0.44
▸ GLA P06280 2/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ FASN P49327 1/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ ACMSD Q8TDX5 1/20 0.43
▸ XDH P47989 1/20 0.43
▸ BIRC5 O15392 1/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ HSD11B1 P28845 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688154 0.90 PDE9A (0.57) PDE9AATMIDO1KDM4EGAA
SCHEMBL32688155 0.89 IDO1 (0.49) PDE9AATMIDO1KDM4EGAA
SCHEMBL32687975 0.88 KDM4E (0.47) PDE9AATMIDO1KDM4EGAA
SCHEMBL32688143 0.86 ALDH1A1 (0.45) PDE9AATMIDO1KDM4EGAA
SCHEMBL32688065 0.86 KDM4E (0.50) KDM4EGAAALDH1A1KMT2AHPGD
SCHEMBL32688442 0.81 ATM (0.52) PDE9AATMIDO1KDM4EGAA
SCHEMBL20339898 0.79 PDE9A (0.49) PDE9AATMIDO1KDM4EGAA
SCHEMBL32688076 0.78 KDM4E (0.50) PDE9AATMKDM4EGAAALDH1A1
SCHEMBL32688005 0.78 PDE9A (0.43) PDE9AIDO1KDM4EKMT2AMEN1
SCHEMBL12681337 0.78 ALDH1A1 (0.43) ATMKDM4EALDH1A1HPGDFASN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK PDE9A 1443/4885ATM 1884/4885IDO1 1284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback